% Expired Patents = 100.0

Trademarks = 1

Forward Citations = 27

Loading Chart...

1 inventor (with patents filed for the assignee):

Jasjit S Suri (5 out of 22 patents)

5 patents: Sort by Forward Citations

1. 8805043 - System and method for creating and using intelligent databases for assisting in intima-media thickness (IMT) (2014-08-12),

2. 8708914 - Validation embedded segmentation method for vascular ultrasound images (2014-04-29),

3. 8639008 - Mobile architecture using cloud for data mining application (2014-01-28),

4. 8532360 - Imaging based symptomatic classification using a combination of trace transform, fuzzy technique and multitude of features (2013-09-10),

5. 8485975 - Multi-resolution edge flow approach to vascular ultrasound for intima-media thickness (IMT) measurement (2013-07-16),

Company Overview

Atheropoint LLC is a leading provider of solutions for cardiovascular disease management, specializing in atheroma imaging and analysis. Their innovative technology helps healthcare professionals assess a patient's risk for heart disease and make informed treatment decisions. With a focus on precision and accuracy, Atheropoint is dedicated to improving patient outcomes and reducing the incidence of cardiovascular events.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#12 in Roseville, CA

#12,070 in California

#51,620 in US

Roseville, CA, United States of America

Atheropoint LLC

Forward Citations = 27

1 inventor:

Jasjit S Suri (5 out of 22 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Atheropoint LLC. Retrieved from https://idiyas.com/company/atheropoint

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]